TENAX THERAPEUTICS, INC. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
TENAX THERAPEUTICS, INC. (TENX) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $118.12 thousand as of 2018-12-31, per its 10-K filed 2019-04-01.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2019-04-01
- 2018-12-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $118.12K.
- 2017-12-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $115.22K.
- 2016-12-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $112.43K.
- 2015-12-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $74.06K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2018-12-31 | $118.12K 10-K · filed 2019-04-01 |
| 2017-12-31 | $115.22K 10-K · filed 2018-04-02 |
| 2016-12-31 | $112.43K 10-K · filed 2017-03-16 |
| 2015-12-31 | $74.06K 10-KT · filed 2016-03-14 |
| 2015-04-30 | $94.92K 10-K · filed 2015-07-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |